Cargando…
Correction: Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2005
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1174971/ http://dx.doi.org/10.1186/ar1750 |
| _version_ | 1782124490712416256 |
|---|---|
| author | Baraliakos, Xenofon Listing, Joachim Brandt, Jan Zink, Angela Alten, Rieke Burmester, Gerd Gromnica-Ihle, Erika Kellner, Herbert Schneider, Matthias Sörensen, Helmut Zeidler, Hennig Rudwaleit, Martin Sieper, Joachim Braun, Juergen |
| author_facet | Baraliakos, Xenofon Listing, Joachim Brandt, Jan Zink, Angela Alten, Rieke Burmester, Gerd Gromnica-Ihle, Erika Kellner, Herbert Schneider, Matthias Sörensen, Helmut Zeidler, Hennig Rudwaleit, Martin Sieper, Joachim Braun, Juergen |
| author_sort | Baraliakos, Xenofon |
| collection | PubMed |
| description | |
| format | Text |
| id | pubmed-1174971 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2005 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-11749712005-07-13 Correction: Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab Baraliakos, Xenofon Listing, Joachim Brandt, Jan Zink, Angela Alten, Rieke Burmester, Gerd Gromnica-Ihle, Erika Kellner, Herbert Schneider, Matthias Sörensen, Helmut Zeidler, Hennig Rudwaleit, Martin Sieper, Joachim Braun, Juergen Arthritis Res Ther Correction BioMed Central 2005 2005-03-23 /pmc/articles/PMC1174971/ http://dx.doi.org/10.1186/ar1750 Text en Copyright © 2005 BioMed Central Ltd |
| spellingShingle | Correction Baraliakos, Xenofon Listing, Joachim Brandt, Jan Zink, Angela Alten, Rieke Burmester, Gerd Gromnica-Ihle, Erika Kellner, Herbert Schneider, Matthias Sörensen, Helmut Zeidler, Hennig Rudwaleit, Martin Sieper, Joachim Braun, Juergen Correction: Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab |
| title | Correction: Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab |
| title_full | Correction: Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab |
| title_fullStr | Correction: Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab |
| title_full_unstemmed | Correction: Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab |
| title_short | Correction: Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab |
| title_sort | correction: clinical response to discontinuation of anti-tnf therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1174971/ http://dx.doi.org/10.1186/ar1750 |
| work_keys_str_mv | AT baraliakosxenofon correctionclinicalresponsetodiscontinuationofantitnftherapyinpatientswithankylosingspondylitisafter3yearsofcontinuoustreatmentwithinfliximab AT listingjoachim correctionclinicalresponsetodiscontinuationofantitnftherapyinpatientswithankylosingspondylitisafter3yearsofcontinuoustreatmentwithinfliximab AT brandtjan correctionclinicalresponsetodiscontinuationofantitnftherapyinpatientswithankylosingspondylitisafter3yearsofcontinuoustreatmentwithinfliximab AT zinkangela correctionclinicalresponsetodiscontinuationofantitnftherapyinpatientswithankylosingspondylitisafter3yearsofcontinuoustreatmentwithinfliximab AT altenrieke correctionclinicalresponsetodiscontinuationofantitnftherapyinpatientswithankylosingspondylitisafter3yearsofcontinuoustreatmentwithinfliximab AT burmestergerd correctionclinicalresponsetodiscontinuationofantitnftherapyinpatientswithankylosingspondylitisafter3yearsofcontinuoustreatmentwithinfliximab AT gromnicaihleerika correctionclinicalresponsetodiscontinuationofantitnftherapyinpatientswithankylosingspondylitisafter3yearsofcontinuoustreatmentwithinfliximab AT kellnerherbert correctionclinicalresponsetodiscontinuationofantitnftherapyinpatientswithankylosingspondylitisafter3yearsofcontinuoustreatmentwithinfliximab AT schneidermatthias correctionclinicalresponsetodiscontinuationofantitnftherapyinpatientswithankylosingspondylitisafter3yearsofcontinuoustreatmentwithinfliximab AT sorensenhelmut correctionclinicalresponsetodiscontinuationofantitnftherapyinpatientswithankylosingspondylitisafter3yearsofcontinuoustreatmentwithinfliximab AT zeidlerhennig correctionclinicalresponsetodiscontinuationofantitnftherapyinpatientswithankylosingspondylitisafter3yearsofcontinuoustreatmentwithinfliximab AT rudwaleitmartin correctionclinicalresponsetodiscontinuationofantitnftherapyinpatientswithankylosingspondylitisafter3yearsofcontinuoustreatmentwithinfliximab AT sieperjoachim correctionclinicalresponsetodiscontinuationofantitnftherapyinpatientswithankylosingspondylitisafter3yearsofcontinuoustreatmentwithinfliximab AT braunjuergen correctionclinicalresponsetodiscontinuationofantitnftherapyinpatientswithankylosingspondylitisafter3yearsofcontinuoustreatmentwithinfliximab |